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Abstract
Background: TPA Induced Sequence 7 acts as a transcriptional co-regulator controlling the expression of genes
involved in differentiation of various cell types, including skeletal myoblasts. We and others have shown that TIS7
regulates adult myogenesis through MyoD, one of the essential myogenic regulatory factors.
Results: Here, we present data identifying ICln as the specific, novel protein downstream of TIS7 controlling
myogenesis. We show that TIS7/ICln epigenetically regulate myoD expression controlling protein methyl transferase
activity. In particular, ICln regulates MyoD expression via its interaction with PRMT5 by an epigenetic modification
that utilizes symmetrical di-methylation of histone H3 on arginine 8. We provide multiple evidences that TIS7
directly binds DNA, which is a functional feature necessary for its role in transcriptional regulation.
Conclusion: We present here a molecular insight into TIS7-specific control of MyoD gene expression and thereby
skeletal muscle differentiation.
Keywords: TIS7, DNA-binding, Methyl transferase, Epigenetic regulation, ICln, MyoD, Myogenesis
Background
Mouse TIS7, its rat PC4 [1], and human Interferon-Related
Developmental Regulator 1 [2, 3] homologues were origin-
ally proposed to act as immediate early genes [1, 4]. TIS7
was found to be upregulated upon c-Jun activation and
translocated to the nucleus [5], where it functions as a
transcriptional co-regulator, activating [2] or repressing gene
expression via interaction with transcription factors and
histone deacetylase [6] complexes [5, 7, 8]. TIS7 protein has
been shown to be involved in the regulation of differenti-
ation processes in multiple cell types, e.g., neurons [4, 9],
enterocytes [10], and myocytes [11, 12]. We have previously
shown that TIS7 knockout (KO) mice are viable and fertile
but suffer from delayed muscle regeneration upon muscle
crush damage, which becomes even more apparent with
increasing age [12]. At the cellular level, primary muscle
satellite cells from TIS7 KO mice displayed significant
differentiation deficiency [12]. This regeneration phenotype
can be explained by reduced differentiation potential caused
by decreased mRNA and protein expression levels of key
muscle regulatory factor MyoD [12] in TIS7 KO muscle sat-
ellite cells (MSCs). We, together with others, have previously
shown that TPA Induced Sequence 7 [7] is a positive re-
gulator of myogenesis and of MyoD levels in particular. Al-
though there is experimental evidence for TIS7-dependent
regulation of multiple proteins related to the control of
MyoD levels and its activity, e.g., depletion of the inhibitory
effect of HDAC4 [2] or downregulation of NF-κB [13], an
exact TIS7-dependent pathway regulating MyoD levels and
thereby myogenesis remained thus far unknown.
Though there is indication that transcriptional regulation
of myogenic regulatory factors (MRFs) myoD, myf5, and
myogenin depends on the enzymatic activity of several
histone modifying enzymes, such as protein arginine N-
methyltransferase 5 [14–16], the mechanism regulating the
particular choice of PRMT5 substrate in adult myogenesis
is yet to be identified. PRMT5 was found in the methylo-
some complex with the protein ICln which, depending on
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its interacting partners, is also involved in transcriptional
regulation (for review see [17]). ICln was shown to be
responsible for the PRMT5 substrate specificity [18].
However, whether ICln levels correlate with the PRMT5
activity and mainly how they are regulated in the process
of myogenesis, remains to be studied.
Herein, we investigated, at the molecular level, how TIS7
may affect skeletal muscle regeneration and the regulatory
processes of myoblast differentiation, in particular, the exact
mechanism by which TIS7 regulates MyoD levels. First of
all, we identified that the TIS7 protein binds directly to
DNA, which substantially clarifies its role in transcriptional
regulation. We confirmed by several independent tech-
niques the physical interaction between the TIS7 protein
and regulatory elements of the ICln gene and even quanti-
tatively determined the relationship between TIS7 binding
and ICln transcriptional regulation. Next, we clarified the
link between PRMT5 and regulation of myoD expression
by showing that ICln levels determine binding of PRMT5
and thereby its methyl transferase activity on histone H3
Arg 8 on particular gene locus, in this case myoD. Finally,
through in vivo experiments, we documented that the
ectopic expression of either TIS7, ICln, or MyoD in MSCs
derived from TIS7 KO mice rescued their diminished dif-
ferentiation potential.
On the basis of our current data, we propose that
TIS7 participates in the mechanism of epigenetic regula-
tion of myogenesis via a novel player ICln, in particular
by its transcriptional regulation.
Results
TIS7 controls myoD levels through epigenetic regulation
of gene expression
Myo5D and MEF2 families of transcription factors are
key regulators of skeletal muscle differentiation [19, 20].
We and others have previously shown that MyoD levels
in myoblasts depend on TIS7 expression [2, 12, 13].
Although the levels of several proteins related to myo-
genesis regulation (HDAC4, NF-kB) have been shown to
be affected by the presence or absence of TIS7 [2, 13],
the explicit mechanism by which TIS7 regulates MyoD
expression is yet to be identified. Therefore, we decided
to first analyze the ability of ectopic TIS7 expression to
restore MyoD mRNA and protein levels in proliferating
TIS7 KO MSCs. Consistent with previous data [12], the
loss of TIS7 caused a significant downregulation of
myoD mRNA levels, which was restored upon ectopic
expression of TIS7 in KO MSCs (Fig. 1a). Western blot
analyses of MyoD showed that (1) Myod D protein
levels were significantly reduced in TIS7 KO MSCs
(approx. 50 % of the WT value) and (2) significant res-
cue was achieved by TIS7 ectopic expression (approx.
80 %) (Fig. 1b).
TIS7 regulates myoD expression by an epigenetic
mechanism
Transcriptional co-regulator arginine methyltransferase
PRMT5 was identified to be necessary for proper myo-
genesis in zebrafish embryonic development, where it
specifically regulates myoD expression [21]. In adult mice,
PRMT5 inactivation abrogated skeletal muscle regene-
ration [14], which resembled the TIS7 KO mouse phe-
notype reported by us [12]. Therefore, we decided to
investigate whether the PRMT5-dependent epigenetic
control mechanism of myoD expression is affected by
TIS7 KO. We first tested the presence of arginine 8
dimethylated histone H3 on the myoD gene. For this
purpose, we performed chromatin immunoprecipitation
(ChIP) using specific anti-histone H3 (sym-dimethyl
Arg8) antibodies followed by quantitative PCR detection
of the myoD regulatory region (Fig. 1c). Our data showed
that there was a significant increase in symmetrical
dimethylation of histone H3 on myoD in TIS7 KO when
compared to wildtype (WT) MSCs (P < 0.00005; Fig. 1d),
although the total amounts of histone H3 were compar-
able (Additional file 1: Figure S1A). The increase in this
modification, which is generally related to transcriptional
inhibition, explained reduced myoD expression in TIS7
KO MSCs. Importantly, the ectopic expression of TIS7 in
KO MSCs significantly (P ≤ 0.001) reduced symmetrical
dimethylation of histone H3 on myoD to levels compar-
able with the WT MSCs. Next, we analyzed by ChIP
whether this difference was directly dependent on PRMT5
recruitment to the myoD regulatory region. As expected,
PRMT5 occupancy on the myoD gene was significantly
higher in TIS7 KO when compared to WT MSCs. As in
the case of H3 methylation, we found that the ectopic
expression of TIS7 significantly reduced PRMT5 binding
to myoD gene in KO MSCs (P ≤ 0.001; Fig. 1e).
ICln expression is downregulated in TIS7 KO MSCs
To understand how TIS7 may affect PRMT5-specific
function in myogenesis we analyzed the effect of ectopic
expression of a known regulator of PRMT5, namely ICln
(37 kDa) [18, 22, 23] in TIS7 WT and KO MSCs. ICln
protein forms a complex with PRMT5 [24] that regulates
its substrate specificity [25]. Therefore, we analyzed
whether PRMT5 epigenetic regulation of myoD transcrip-
tion was related to ICln levels. Under an identical experi-
mental setup as described above (Fig. 1d, e), we analyzed
chromatin isolated from TIS7 WT and KO MSCs,
transiently transfected either with control YFP or with a
YFP-ICln construct. Immunoprecipitation with both
anti-histone H3 (sym-dimethyl Arg8) and anti-PRMT5
antibodies revealed an increase in Arg8 dimethylated
histone H3 and PRMT5 bound to myoD regulatory
elements in TIS7 KO MSCs, respectively (Fig. 2a, b).
Constitutive expression of ICln significantly (P ≤ 0.0001)
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decreased the amount of symmetrically dimethylated H3
Arg8 (P ≤ 0.001) on myoD regulatory elements; this effect
could be explained either by increased PRMT5 enzymatic
activity or changes in its binding to chromatin. Two
different independent methylation assays unveiled that the
presence of ICln had no effect on total PRMT5 enzymatic
activity both in vitro and in vivo (Additional file 1: Figure
S1C and D). We also could not detect any difference in
subcellular distribution of PRMT5 (data not shown). How-
ever, our ChIP experiments revealed that the ectopic ex-
pression of ICln substantially decreased the symmetrically
dimethylated arginine 8 histone H3 and PRMT5 recruit-
ment to myoD regulatory elements (Fig. 2a, b). The level of
chromatin-associated PRMT5 in ICln-complemented TIS7
KO MSCs was similar to that observed in WT cells. Next,
we checked whether ICln ectopic expression in TIS7 KO
Fig. 1 TIS7 epigenetically regulates MyoD expression. a TIS7 KO MSCs were transfected with indicated plasmids. Quantitative PCR analysis of myoD was
normalized to GAPDH expression (n = 3 independent experiments). Values represent the mean ± SEM and resulting data were analyzed via two-tailed type
2 Student’s t-test, *** P< 0.001 and * P< 0.05. b Proliferating TIS7 KO MSCs were transfected with indicated plasmids and total cell lysates were probed with
MyoD and control antibodies. Quantification (n = 3 biological replicates) was performed by normalization to the tubulin signal. Values represent the mean
± SD and resulting data were analyzed via two-tailed type 2 Student’s t-test, *** P< 0.001 and ** P< 0.01. Representative western blots are shown. ChIP
analyses using chromatin from TIS7 WT or KO MSCs transfected with either GFP or GFP-TIS7 plasmid DNA. c Schematic outline of mouse myoD gene locus.
Primer pairs used for ChIP assays are indicated by arrows. The alignment of human and mouse sequences amplified by the PCR is shown. Antisera directed
against symmetrically di-methylated histone H3 at arginine 8 (d) or PRMT5 (e) were used for immunoprecipitation. Immunoprecipitated DNA was analyzed
by qPCR in triplicates using primers specific for the mouse myoD regulatory region. ChIP with control rabbit IgG or 1.23 % of total chromatin (input) were
used as controls. Signals were normalized to input chromatin and shown as percentage of input, ** P≤ 0.001 and *** P< 0.00005
Lammirato et al. BMC Biology  (2016) 14:95 Page 3 of 14
MSCs rescued the myoD expression. As shown in Fig. 2c,
the ectopic ICln expression rescued MyoD protein levels
due to increased myoD transcription, as documented by
elevated myoD mRNA (Fig. 2d). Thereafter, we asked
ourselves whether PRMT5-mediated methylation of the
myoD regulatory region is solely responsible for TIS7/ICln-
mediated regulation of myoD transcription. Therefore, we
generated, by lentiviral transduction and antibiotic selec-
tion, a stable and specific PRMT5 knockdown in TIS7 KO
MSCs (Fig. 2e and Additional file 1: Figure S1B). qPCR
analysis of myoD levels in proliferating TIS7 KO MSCs did
not show any difference between control sh GFP and sh
PRMT5 expressing cells (data not shown). However, after
7 days in differentiation medium, at a time point when WT
TIS7 MSCs fully differentiate, we identified an 80 % in-
crease in myoD RNA levels of sh PRMT5-expressing TIS7
KO MSCs (Fig. 2e). Based on these results we concluded
that PRMT5-dependent methylation of histone H3 bound
to myoD regulatory elements is not the main regulatory
mechanism in proliferating TIS7 deficient cells, suggesting
that other TIS7-dependent mechanisms may contribute to
this regulation. However, PRMT5-regulated methylation
Fig. 2 ICln affects in vivo methylation of histone H3 and binding of PRMT5 to myoD locus, resulting in increased myoD RNA and protein levels.
ChIP analysis using chromatin from TIS7 WT or KO MSCs transfected with either YFP or YFP-ICln plasmids. Antisera directed against symmetrically
dimethylated histone H3 at arginine 8 (a) or PRMT5 (b) were used for immunoprecipitation. Immunoprecipitated DNA was analyzed in triplicate
by qPCR using primers to amplify the mouse myoD regulatory region. ChIP with control rabbit IgG or 1.23 % of total chromatin (input) were used
as controls. Signals were normalized to input chromatin and shown as percentage of input. ** P ≤ 0.001 and *** P < 0.00005. c TIS7 KO MSCs were
transfected with indicated plasmids and total cell lysates were probed with anti-MyoD and anti-YFP antibodies. Quantification (n = 3 biological
replicates) was performed by normalization to the tubulin signal. Representative immunoblots are shown. d TIS7 KO MSCs were transfected with
the indicated plasmids. Quantitative PCR analysis of myoD was normalized to GAPDH expression (n = 3 biological replicates and ** P < 0.01). e
PRMT5 knockdown significantly increased myoD RNA levels in TIS7 KO MSCs transduced with sh PRMT5-expressing lentivirus. myoD RNA levels
were measured by qPCR and PRMT5 protein levels were documented by immunoblots with indicated antibodies
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significantly affected myoD expression during the differen-
tiation of MSCs.
We thus conclude that ICln regulates MyoD expres-
sion in MSCs by changing the epigenetic status of chro-
matin through functional interference with PRMT5.
The next question raised was whether there were
significant differences in ICln levels between TIS7 KO
and WT MSCs. Western blot analyses of several inde-
pendent biological experiments (n ≥ 3) revealed that ICln
protein levels were significantly reduced in both prolifer-
ating (PM) and differentiating (DM) KO MSCs (to 53 %
and 46 %, respectively) (Fig. 3a) when compared to TIS7
WT MSCs. Ectopic expression of TIS7 restored the ICln
protein levels up to 90 % of the WT values, suggesting
the role of TIS7 in its regulation (Fig. 3b).
We observed the same trend also in mRNA levels
where ICln expression was approximately 50 % lower in
both PM and DM TIS7 KO MSCs (Fig. 3c). Similarly to
protein, the level of ICln mRNA was significantly upreg-
ulated by TIS7 ectopic expression (Fig. 3d), indicating
possible TIS7 involvement in ICln transcriptional regula-
tion. To test this, we transiently transfected WT and
TIS7 KO MSCs with an ICln promoter-driven reporter
construct and measured the luciferase activities. These
were reduced in TIS7 KO MSCs and efficiently rescued
by ectopic expression of TIS7 (Fig. 3e) showing that the
activity of ICln promoter is dependent on TIS7. Since
little is known about ICln gene regulation [26], we applied
luciferase assays using reporter constructs possessing
various promoter truncations. These experiments revealed
a 41 nt sequence (–154 to –113) representing a minimal
essential region required for ICln transcriptional activity in
WT MSCs (Fig. 4a).
TIS7 directly binds to and activates ICln promoter
Next, we tested whether this 41 nt sequence was sufficient
to regulate ICln expression in a TIS7-dependent manner.
We generated a luciferase reporter construct, which con-
tained two repeats of the 41 nt sequence (–154 to –113) of
the ICln promoter upstream of the luciferase gene. WT
MSCs transfected with this construct displayed increased
luciferase activity when compared to the empty pGL3B
luciferase vector (P > 0.001). This basal activity was
significantly induced (P > 0.001) by co-transfection with
TIS7 (Fig. 4b). Even stronger luciferase activity was found
when four repeats of the 41 nt sequence were cloned
upstream of the luciferase gene (5.1-fold induction reporter
only and 14.5-fold induction when co-transfected with
TIS7). These data demonstrated the functional relevance of
this minimal essential region for TIS7-mediated activation
of ICln transcription. Using bioinformatics prediction
software (DISIS (www.predictprotein.org), BinDN+ (http://
bioinfo.ggc.org/bindn+/), DP-Bind (http://lcg.rit.albany.edu/
dp-bind/), and DNABindR (http://turing.cs.iastate.edu/Pred
DNA/); Additional file 2: Figure S2) we identified, with 70–
80 % probability, three distinct DNA-binding domains in
the TIS7 protein. This prediction suggested that the TIS7
protein may directly bind DNA. We tested this possibility
by an electrophoretic mobility shift assay using an oligo-
nucleotide probe containing the (–154 to –113) sequence
of the ICln promoter. As shown in Fig. 4c, we detected a
specific band representing a complex of GST-TIS7 with a
bound fluorescently labeled oligonucleotide probe (lane 4).
The specificity of this complex was confirmed by the fact
that this complex was not formed when the probe was
incubated with GST alone (lane 3). Additionally, TIS7
binding to the labeled probe was specifically blocked by
pre-incubation with a 20-fold access of a non-labeled “cold”
oligonucleotide (lane 2). The presence of TIS7 in this DNA
complex was further confirmed by pre-incubation with a
TIS7-specific antibody, which caused a “supershift”, i.e., fur-
ther slowed the mobility of the complex on the native poly-
acrylamide gel (lane 5). In addition, we have quantified the
specific binding of TIS7 to this DNA oligonucleotide using
surface plasmon resonance. The measurements showed
that (1) the protein binding moiety is specific (recombinant
GST protein did not bind to the oligonucleotide probe) and
(2) the TIS7-binding was sequence specific because there
was a 10-fold difference in Kd values between the native (–
154 to –113) ICln promoter (Fig. 4d) and “scrambled” se-
quences. Using ChIP analysis, we investigated whether
TIS7 binds a native ICln promoter in MSCs. We found that
TIS7 was bound to the ICln promoter in TIS7 WT but not
KO MSCs (Fig. 4e). The specificity of TIS7 binding was
confirmed using control rabbit IgG.
Based on the results of these analyses we conclude that
TIS7 directly binds ICln promoter DNA and thereby posi-
tively regulates ICln transcription in MSC cells.
TIS7 regulates myotube formation through ICln and
MyoD expression
To understand how TIS7 regulates skeletal muscle differ-
entiation, we characterized in detail the morphological
differences between primary WT and TIS7 KO MSCs. In
general, proliferating MSCs could be induced to differenti-
ate into mature myotubes within 5–7 days. Although
plated at the same density, while 70 % of WT MSCs
differentiated into myotubes, only 30 % of TIS7 KO MSCs
formed myotubes (Fig. 5a, b). This defect was completely
restored by ectopic TIS7 expression. Importantly, the
ectopic expression of MyoD in TIS7 KO MSCs led to full
recovery of the differentiation deficit and restored
myotubes formation in these cells (Fig. 5a, b). Because of
TIS7-dependent regulation of ICln we investigated
whether ICln can act downstream of TIS7 to regulate
myogenesis. Ectopic ICln expression in TIS7 KO cells res-
cued myotube formation in TIS7 KO MSCs, similar to the
effects of TIS7 or MyoD overexpression (Fig. 5a, b).
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Fig. 3 TIS7 regulates ICln protein and RNA levels. a Quantitative analyses of ICln protein expression in proliferating (PM; n = 4 biological replicates)
and differentiating (DM; n = 3 independent experiments) MSCs. Equal amounts of total cell lysates were probed by immunoblotting with anti-ICln
antibodies and normalized by tubulin. b TIS7 ectopic expression rescued ICln protein levels in TIS7 KO MSCs. Proliferating TIS7 KO MSCs were
transfected with GFP plasmid as a control or with GFP-TIS7 plasmid constructs and total cell lysates were probed with the indicated antibodies.
Quantification (n = 3 biological replicates) was based on tubulin signal. Representative western blots are shown. c Quantitative PCR analysis of ICln was
normalized to GAPDH expression (n = 3 biological replicates). d TIS7 overexpression rescued ICln RNA levels in TIS7 KO MSCs. Proliferating TIS7 KO
MSCs were transfected with indicated plasmids and ICln quantitative PCR was performed as in panel c. e TIS7 transcriptionally regulates ICln levels.
Proliferating WT MSCs were transiently co-transfected with full length ICln promoter-luciferase reporter construct, β-galactosidase expression plasmid,
and GFP plasmid as a control or GFP-TIS7 plasmid constructs. Luciferase values were normalized to β-galactosidase values. In all graphs, values repre-
sent the mean ± SD and resulting data were analyzed via two-tailed type 2 Student’s t-test, *** P < 0.001, ** P < 0.01, and * P < 0.05
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A more detailed quantitative analysis revealed that the
majority of TIS7 KO MSCs (>50 %) remained mononucle-
ated and the very large myotubes containing more than 15
nuclei were completely missing in TIS7 KO MSCs
(Fig. 5c). Ectopic TIS7 expression rescued the appearance
of multinucleated cells, mainly the category of myotubes
with more than 15 nuclei. Even more interestingly, the
ectopic expression of MyoD reverted the distribution of
different groups of multinucleated myotubes similar to
that of TIS7 WT MSCs and recovered in TIS7 KO MSCs
Fig. 4 A defined 42 nucleotide stretch within the ICln promoter represents the minimal region essential for TIS7-regulated ICln transcription. a Proliferat-
ing TIS7 WT MSCs were transiently co-transfected with indicated ICln promoter-luciferase reporter constructs and with β-galactosidase expression plasmid
for transfection control. The activity of the WT full length ICln promoter-driven luciferase reporter was set as 100 %. Values represent the mean ± SEM of
at least three biological replicates. b Activities of luciferase reporter constructs driven by two or four (–154/–113) repeats from ICln promoter. Bars marked
+ TIS7 represent samples co-transfected with GFP-TIS7 plasmid vector. Control samples were co-transfected with GFP plasmid. c TIS7 binds to the
minimal essential region necessary for the TIS7-regulated transcription of ICln. GST (lane 3) or GST-TIS7 (lanes 2, 4, and 5) recombinant proteins were
incubated with the fluorescently labeled oligonucleotide probe containing the –154/–113 sequence of the ICln promoter. d Specific TIS7 binding to ICln
minimal essential region (MER) determined by surface plasmon resonance measurements (SPR). Oligonucleotides representing either the ICln MER or its
scrambled version were incubated with increasing concentrations of GST-TIS7 or GST alone as indicated. SPR steady-state response values (single values)
are presented as a function of protein concentration (lines). Kd = dissociation constant. e ChIP analysis of TIS7 binding to the ICln promoter region.
Chromatin from TIS7 WT and KO MSCs was immunoprecipitated as above using either specific antibody against TIS7 or control rabbit IgG
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the missing group of very large myotubes with more than
15 nuclei (Fig. 5c). Similarly, the increased number of
multinucleated cells and, specifically, the formation of very
large myotubes with more than 15 nuclei (Fig. 5c) were
observed in ICln-transfected cells. MyoD as a crucial myo-
genic regulatory factor is responsible for the myoblast
differentiation leading to myotube formation and, based
on data shown here, we concluded that TIS7 regulates
ICln transcription and thereby MyoD levels responsible
for reversion of the TIS7 KO phenotype in MSCs.
Discussion
In this study, we show that ICln, a protein with multiple
physiological functions that depend on its subcellular
localization and mainly on its protein interacting partners
[17], represents a novel regulator of skeletal myoblast
differentiation. We identified that TIS7 transcriptionally
regulated ICln via direct binding to its promoter and,
secondly, that ectopic expression of ICln rescued the dif-
ferentiation deficiency of TIS7 KO MSCs. ICln controlled
muscle differentiation through the MyoD pathway since
Fig. 5 MSC differentiation is regulated by MyoD, ICln, and TIS7. a TIS7 WT and KO MSCs were plated at the same cell density. Proliferating TIS7
KO MSCs were transfected with indicated plasmids and 6 h later the differentiation was induced. After 5 d of differentiation, cells were fixed,
stained with anti-myosin heavy chain antibody MF 20, and the nuclei were visualized using Hoechst. Scale bar = 100 μm. b Percentage of MSC
fusion was calculated as the number of nuclei localized in multinucleated (n > 2) myotubes defined by MF20 staining compared to the total
number of nuclei. Vertical bars denote the mean ± SD and were calculated from independent biological replicates (n = 3). The indicated number
of nuclei was evaluated. Resulting data were analyzed via two-tailed type 2 Student’s t-test, *** P < 0.001. c Quantitative analysis of cells with the
indicated nuclei numbers per cell defined by myosin staining. This analysis showed a significant decrease in the number of multinucleated cells
and a completely missing category of cells with more than 15 nuclei in TIS7 KO MSCs when compared to TIS7 WT MSCs. Ectopic expression of
TIS7, MyoD, or ICln significantly increased the number of multinucleated cells, mainly those with more than 15 nuclei in TIS7 KO MSCs when
compared to TIS7 WT MSCs
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ICln upregulated MyoD levels. Our further results pre-
sented here provide evidence for the epigenetic regulation
of myoD transcription by ICln.
Adult muscle regeneration depends on de novo myo-
genesis, which requires activation and commitment of
quiescent satellite cells. Muscle regeneration ability is
regulated by and depends on the differentiation potential
of MSCs [27–29]. This is assured by the interplay of
MRFs MyoD, myogenin, Myf5, and Myf6 (MRF4, hercu-
lin) [19, 30, 31]. MyoD and Myf5 are required for myo-
genic determination [32], whereas myogenin and Myf6
are markers of terminal differentiation [29]. Muscle
damage induces MSC proliferation followed by differen-
tiation resulting in the formation of new muscle fibers.
MyoD is required in both processes; however, myoblast
differentiation initiation and progression is governed by
an interplay of MyoD with other muscle-specific factors,
e.g., Myf5 and myogenin [33]. MyoD KO mice indicate a
unique requirement of MyoD during adult muscle re-
generation rather than during embryonic development
[29]. We found that the myoD regulation at this stage of
myogenesis is tightly regulated by the TIS7/ICln/PRMT5
axis. Depletion of TIS7 or reduced level of ICln caused
the epigenetic inhibition of myoD leading to the general
differentiation deficiency phenotype characterized by di-
minished myoblast fusion. These findings indicate that
the maintenance of specific MyoD levels by the TIS7/
ICln/PRMT5 axis is critical for the induction and early
progression of myoblast differentiation. It remains to be
clarified whether this pathway is responsible for the
regulation of other MRF genes.
Myogenic gene expression is affected by chromatin re-
modeling enzymes such as histone acetylases and deace-
tylases, histone lysine methyltransferases, SWI/SNF
family of ATP-dependent enzymes, and protein arginine
methyltransferases [34, 35]. Among them, PRMT5 was
identified in several independent studies as one of the
critical epigenetic regulators of myogenesis. PRMT5 was
shown to control the expression of the MRFs myogenin,
MyoD, and Myf5 in zebra fish embryos [21]. It was also
shown that PRMT5 is involved in transcriptional regula-
tion of various other myogenic genes via symmetric ar-
ginine dimethylation of histones and components of the
transcriptional machinery [15, 21]. PRMT5 facilitates the
recruitment of Brg1-ATPase, associated with Swi/Snf
chromatin remodeling enzymes, and MyoD to the pro-
moter of myogenin via H3 Arg8 dimethylation resulting
in upregulation of myogenin transcription [15]. The
same H3 Arg8 modification by PRMT5 exerts transcrip-
tional repression effect on the p21 gene that facilitates
MSC proliferation and expansion, which has a positive
impact on the process of muscle regeneration. As a part
of the methylosome, PRMT5 also methylates and facili-
tates the recruitment of Sm proteins to the survival
motor neuron complex leading to its activation [22, 36].
Interestingly, the loss of survival motor neuron-specific
activity is observed in primary myoblasts from patients
with the autosomal recessive disorder spinal muscular
atrophy. These myoblasts display a strong fusion defi-
ciency, implying a primary muscle defect along with the
well-described neuronal degeneration [37, 38]. We
present here new evidence for a contrasting, but not
conflicting, function of PRMT5 in the regulation of
myogenesis that is associated with inhibition of myoD
expression. PRMT5 represses myoD expression using a
similar epigenetic mechanism described for p21 gene
that is mediated through H3Arg8 symmetrical dimethy-
lation at the myoD locus. This inhibits induction and
early progression of MSC differentiation into myotubes,
which could represent the mechanism that together with
p21 inhibition [14] contributes to the maintenance of
the proliferative potential of adult MSCs. In this sce-
nario, PRMT5 would allow efficient accumulation of a
critical MSC mass that could be committed to differenti-
ation upon receiving specific stimuli. The open question,
however, remains how this PRMTR5 function is con-
trolled in MSCs. It has been shown before that PRMT5-
specific cellular functions are regulated by its interacting
partners [39]. ICln, the component of the methylosome
complex, was shown to directly interact with PRMT5
and change its substrate specificity. In the presence of
ICln, PRMT5 methylation of Sm proteins is stimulated,
but methylation of histones is inhibited [23]. Consistent
with these studies, we also observed that ICln ectopic
expression inhibited methylation of histone H3 in MSCs.
This was achieved via inhibition of PRMT5 binding to
the myoD gene (Fig. 2b) rather than changing PRMT5
enzymatic activity (Additional file 1: Figure S1C and D).
The recruitment of PRMT5 to the regulatory elements
of genes needs complex formation with DNA-binding or
chromatin-associated adaptor proteins [40, 41]. We
propose that formation of such a complex on the myoD
gene is prevented by the interaction of PRMT5 with
ICln. Similarly, formation of an alternative PRMT5 com-
plex has been described for protein RioK1, which com-
petes with ICln for binding to PRMT5 [18]. This would
lead to diminished H3 Arg8 methylation thereby de-
repressing myoD expression.
ICln has been found to stimulate PRMT5-mediated
Sm protein methylation and at the same time to inhibit
the nuclear function of PRMT5, namely methylation of
histones [23]. Silencing of ICln was shown to cause α-
motor axon degeneration [42], as seen in patients suffer-
ing from spinal muscular atrophy. There is a substantial
body of knowledge on ICln functions, its interaction
with other proteins and subcellular localization. How-
ever, the regulation of ICln gene expression remains to
be solved. Here, we found a mechanism related to
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myogenesis where TIS7 transcriptionally activates ICln
through binding to the newly identified regulatory
element in the ICln gene. Thus, we propose that myoD
expression in MSCs is epigenetically regulated via ICln/
PRMT5 downstream of TIS7. This notion is supported
by the following facts: (1) deletion of PRMT5 prevented
MSC differentiation [14], which was a phenotype
strikingly reminiscent of TIS7 KO MSCs; (2) PRMT5-
specific symmetrical dimethylation of H3 Arg8 at the
myoD gene was enhanced in TIS7 KO MSCs; and (3)
TIS7 or ICln ectopic expression reduced H3 Arg8
methylation at the myoD gene and rescued the muscle
differentiation deficiency in TIS7 KO MSCs. Further-
more, overexpression of PRMT5 alone in TIS7 KO
MSCs did not rescue their fusion (data not shown),
which was consistent with the inhibitory role of PRMT5
in MSC-specific myoD regulation.
Conclusion
As summarized in Fig. 6, we propose here a novel model
for TIS7 function in myogenesis, where TIS7 upregulates
ICln transcription in MSCs via direct binding to the
regulatory element in the promoter of this gene. Increase
in ICln transcription leads to accumulation of ICln protein
in the cytoplasm and nucleus. The increased amount of
ICln protein inhibits PRMT5 recruitment to the myoD
locus and prevents the methylation of histone H3 at Arg 8.
Decreased methylation de-represses myoD expression,
which is critical for MSC differentiation. It is likely that
PRMT5 controls MyoD levels to balance the proliferation
and differentiation potential of MSCs. Thus, the compo-
nents of this pathway and mainly their regulation could be
seen as targets for development of new therapeutic ap-
proaches for treatment of skeletal muscle diseases.
Methods
Isolation and cultivation of primary muscle satellite cells
(MSCs)
Primary MSCs were isolated from lower hind limb
muscle of 2- to 3-month old TIS7 WT and KO mice as
described previously [43]. The generation of the TIS7
KO mouse, cell culture conditions, and reagents were
described before [12]. Briefly, cells were proliferated in
Ham’s F-10 medium without glutamine, supplemented
with 20 % non-heat-inactivated fetal calf serum (FCS
gold, GE Healthcare) and penicillin-streptomycin (GE
Healthcare); 2.5 ng/mL recombinant bFGF-basic (Pepro-
Tech) was added freshly. Cells were differentiated in
high-glucose DMEM, supplemented with 2 % non-heat-
inactivated horse serum and penicillin-streptomycin (GE
Healthcare). MSCs were grown on cell culture dishes
coated with collagen from calf skin (Sigma).
GST-TIS7 purification and pull-down assays
GST-TIS7 was expressed in E. coli BL21 by addition of
IPTG to 0.1 mM final concentration and incubation at
20 °C overnight. The recombinant protein was purified
using a GSTrapFF column with glutathione Sepharose
beads (GE Healthcare). Elution was initiated with lysis
buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 10 μg/mL
aprotinin, 1 μg/mL pepstatin, 1 μg/mL leupeptin,
0.4 mM Pefablock SC containing 10 mM glutathione
(Sigma)). Additional purity was achieved via gel filtra-
tion, using a Sepharyl S200 column (GE Healthcare).
The GST-TIS7 sample was dialyzed against 50 mM Tris
pH 7.4, 150 mM NaCl.
Immunofluorescence microscopy
Cells were fixed with 4 % paraformaldehyde, permeabilized
with 0.2 % Triton X-100 PBS and blocked with 1 % bovine
serum albumin, 5 % horse serum, and 15 % goat serum
(Thermo Fisher Scientific) in PBS. Samples were incubated
with primary antibodies for 1 h, with secondary antibodies
for 30 min and mounted in Mowiol (Merck Millipore). Im-
ages were acquired using an AxioImager M1.2 microscope
Fig. 6 Model of myogenesis regulation by the TIS7/ICln/PRMT5
pathway. In skeletal muscles, TIS7 transcriptionally regulates ICln.
The accumulated ICln interacts with PRMT5 and prevents its
recruitment to chromatin-bound complexes on the myoD gene. This
regulates PRMT5-mediated symmetrical dimethylation of histone H3
Arg8 and myoD expression. The regulated myoD level affects the
balance between proliferation and differentiation of MSCs
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(Carl Zeiss) and processed with AxioVision Release 4.5 SP1
software.
Preparation of MSC total cell lysates and immunoblotting
MSC lysates were prepared as previously described;
however, using RIPA buffer (50 mM Tris, pH 8.0,
150 mM NaCl, 1 % NP-40, 0.5 % sodium deoxycholate,
0.1 % SDS) supplemented with 10 μg/mL aprotinin,
1 μg/mL pepstatin, 1 μg/mL leupeptin, 0.4 mM Pefa-
block SC (Sigma). Equal amounts of soluble proteins
were separated by SDS-PAGE, transferred to PVDF
membranes (GE Healthcare) and blocked with 3 % BSA
(GE Healthcare) PBS, 1 mM EDTA, and 0.05 % Tween
20 (blocking buffer). Primary antibodies were resolved in
blocking buffer containing 0.02 % sodium azide and
incubated for at least 2 h. After washing (200 mM Tris/
HCl, pH 7.5, 250 mM NaCl and 0.05 % Tween 20) mem-
branes were incubated with horseradish peroxidase-
conjugated secondary antibody in 5 % milk powder in
PBS for 40 min and, after washing, proteins were visual-
ized by the ECL-system (Sigma). Signal intensities were
measured using the Imaging System FluorChem 5500
and quantifications were performed normalizing signals
to tubulin (AlphaEaseFC software).
Transfection of MSC, protein expression rescue and
fusion rescue experiments
MSCs were seeded on collagen-coated plates, cultured
overnight, and transfected with plasmid DNA using
Lipofectamine LTX with PLUS reagent (Thermo Fisher
Scientific). For protein expression analyses, total cell
lysates were generated 24 h later and western blots were
performed as described above. In case of fusion rescue
analyses, growth medium was replaced by differentiation
medium 6 h post transfection. Cells were fixed with 4 %
paraformaldehyde 5 days after transfection. Myoblasts and
myotubes were identified by immunofluorescence micros-
copy using muscle-specific anti-myosin heavy chain
antibody (MF-20) and Hoechst staining for detection of
nuclei. Images were acquired using an AxioImager M1.2
microscope (Carl Zeiss) and processed with AxioVision
Release 4.5 SP1 software. The fusion potential of was
analyzed as follows: (number nuclei within fused myo-
blasts (≥2)/total number of nuclei) × 100. Resulting data
were analyzed via two-tailed type 2 Student’s t-test. Trans-
fection efficiency was approximately 35 %.
Isolation of RNA and quantitative real time PCR
Total RNA was isolated from MSCs using TRIzol reagent
(Thermo Fisher Scientific). After chloroform-extraction
and isopropanol precipitation, resulting RNA yield and
purity was determined with a spectrophotometer. cDNAs
were obtained by reverse transcription of DNaseI treated
RNA using a Revert Aid First Strand cDNA Synthesis Kit
(Thermo Fisher Scientific) with oligo dT primers. Quanti-
tative RT-PCR was performed using TaqMan Gene Expres-
sion Assays (Applied Biosystems) specific for ICln (assay ID
Mm00445821_m1), MyoD (assay ID Mm00440387_m1),
and GAPDH (assay ID Mm99999915_q1) for normalization
to enable quantification by the comparative ddCt method.
The amplification of cDNA was performed by PikoReal
System (Thermo Scientific). Resulting data were analyzed
via two-tailed type 2 Student’s t-test.
Transient transfections and luciferase assays
MSCs were seeded on collagen-coated plates, cultured
overnight and co-transfected with indicated plasmid DNA
and pCMV-β-Gal using Lipofectamine LTX with PLUS
reagent (Thermo Fisher Scientific). Luciferase intensities
were normalized to β-galactosidase activity. Cells trans-
fected with the equal amount of empty vector DNA
served as control. Cells were harvested 48 h post-
transfection in 0.25 M Tris, pH 7.5, 1 % Triton X-100
buffer, and assayed for both luciferase and β-galactosidase
activities. Transfections were performed in triplicate and
all experiments were repeated more than three times.
Electrophoretic motility shift assay
The promoter region of ICln was derived from the clone
P1R3 of the human genomic P1 library (Ressourcen-Zen-
trum/Primär Datenbank RZPD library) [26]. The sequences
of oligonucleotides used for the assay (minimal essential
region necessary for ICln transcription) were 5′TAGAATG
TCTCATCTCTATGGTCGACGGCGTTCAGATTCCG3′
and its complementary strand 5′ CGGAATCTGAACGCC
GTCGACCATAGAGATGAGACATTCTA3′ correspond-
ing to the region spanning from –154 to –113 upstream of
the first ATG codon of the ICln gene. Briefly, 1 μg of
fluorescently labeled IRDye 700-labeled oligonucleotides
(Metabion), representing the minimal essential region
necessary for ICln transcription, was incubated with recom-
binant GST or GST-TIS7 proteins for 10 minutes. Where
indicated, the complex was pre-incubated for 20 minutes
either with a specific TIS7 antibody or with a 20-fold excess
of not labeled oligonucleotides (Sigma). Samples were
analyzed on a 5 % native polyacrylamide gel containing
50 mM Tris, pH 7.5, 0.38 M glycine, and 2 mM EDTA at a
constant voltage of 180 V for ca. 30 minutes in TBE buffer.
Chromatin immunoprecipitation (ChIP)
Chromatin was isolated from TIS7 WT and KO
formaldehyde-treated MSCs using the EpiSeeker Chro-
matin Extraction Kit (ab117152, Abcam) according to the
manufacturer’s protocol. ChIP analyses were carried out
as described previously [44]. In brief, sonicated chromatin
was centrifuged at 15.000× g for 10 min at 4 °C, and the
supernatant (65 μg of sheared DNA per each IP) was
diluted 10-fold with cold ChIP dilution buffer containing
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16.7 mM Tris-HCl pH 8.1, 167 mM NaCl, 0.01 % (w/v)
SDS, 1.1 % (w/v) Triton X-100, and 1.2 mMEDTA supple-
mented with protease inhibitors. Diluted chromatin
samples were pre-cleared for 1 h with 55 μL of 50 %
suspension of protein A sepharose (Protein A Sepharose
CL-4B, GE Healthcare N: 17-0780-01) beads that were
blocked with 0.2 μg/μL sonicated herring sperm DNA
(Thermo Fisher Scientific, N: 15634-017) and 0.5 μg/μL
BSA (B9000 S, NEB). Immunoprecipitations were per-
formed using 4 μg of antibodies at 4 °C overnight.
Immune complexes were collected with 75 μL of 50 %
suspension of protein A Sepharose for 1 h at 4 °C followed
by centrifugation at 1000 rpm and 4 °C for 5 min using a
table top centrifuge. The beads carrying the immune
complexes were washed once with 1 mL low salt wash
buffer (20 mM Tris-HCl pH 8.1, 150 mM NaCl, 0.1 % (w/
v) SDS, 1 % (w/v) Triton X-100 (Merck), 2 mM EDTA),
once with high salt wash buffer (20 mM Tris-HCl pH 8.1,
500 mM NaCl, 0.1 % (w/v) SDS, 1 % (w/v) Triton X-100
(Merck), 2 mM EDTA), once with LiCl wash buffer
(10 mM Tris-HCl pH 8.1, 250 mM LiCl, 1 % (w/v) sodium
deoxycholate, 1 % (w/v) IGEPAL-CA630, 1 mM EDTA)
for 5 min at 4 °C on a rotating wheel, and finally twice with
1 mL TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA).
Protein-DNA complexes were eluted from antibodies by
adding a freshly prepared elution buffer containing 1 %
SDS and 0.1 M NaHCO3. The eluate was reverse cross
linked by adding 5 M NaCl to a final concentration of
0.2 M and incubating at 65 °C for 4 h. Afterwards, the
eluate was treated with Proteinase K at 45 °C for 1 h. The
immunoprecipitated DNA was then isolated by phenol/
chloroform precipitation and used as a template for
real-time quantitative PCR. A primer pair (5′-ACAGCA-
GACGACTTCTATGATGAC-3′/5′- GTGCACCGCAG
TAGGGAAG-3′) specific for region 872/1009 of the my
oD gene (ENSMUSG00000009471) and (5′-TGACCTT-
CAAAGAGAACCACATAG-3′/5′-CCCGGAAGCAGT
AGTCGTAG-3′) for the ICln promoter region were used
for amplification; reactions with rabbit IgG or with 1.23 %
of total chromatin (input) were used as controls. For
real-time quantitative PCR a PikoReal System (Thermo
Scientific) was used. Signals were normalized to input chro-
matin and shown as percentage input. The raw cycle
threshold (Ct) values of the input were adjusted to 100 %
by calculating raw Ct – log2(100/input). To calculate the
percentage input of the immunoprecipitations, the equation
100 × 2[Ct (adjusted input to 100 %) – Ct (IP)] was applied.
Surface plasmon resonance (SPR)
5′-biotinylated single strand sense and complementary
non-biotinylated antisense strand oligonucleotides were pur-
chased from Sigma. The complementary oligonucleotides
were annealed in a buffer containing 30 mM Na3PO4,
200 mM NaCl, and 1 mM dithiothreitol (DTT), pH 7.2 [45].
Annealed oligonucleotides were immobilized on Sensor
Chip SA (GE Healthcare) according to the manufacturer’s
protocol. The sensor chip carrying the target oligonucleo-
tide was then exposed to different concentrations of recom-
binant GST-TIS7 or GST alone in a Biacore™ X100 (GE
Healthcare). Surface plasmon resonance signals were mea-
sured and the dissociation constant (Kd) was determined.
Methylation assay
HEK 293 T cells (ATCC® CRL-3216™) were transiently
transfected with pcDNA3.1 or pcDNA3.1 myc-PRMT5
plasmids alone or co-transfected with ICln-YFP expressing
plasmid using calcium phosphate precipitation. After
24 hours, ectopic myc-PRMT5 was immunoprecipitated
using anti-c-myc (9E10) antibody as previously described
[46] and then incubated with 4 μg of purified core histones
(Sigma) in 30 μL methylation buffer (50 mM HEPES
(pH 7.9), 60 mM NaCl supplemented with 0.8 μCi S-ade-
nosyl-L-(methyl-3H) methionine (3H-SAM) (GE Health-
care) for 1 h at 30 °C. Different amounts of the purified
recombinant His-ICln were added to the methylation
reactions 10 min prior the addition of radioactive SAM.
Reactions were stopped by adding 2× SDS-PAGE sample
buffer followed by heating at 95 °C for 5 min. Samples were
subsequently analyzed by SDS-PAGE and autoradiography.
Plasmids
Full length mouse TIS7 (mTIS7), human PRMT5 (hPRMT5,
Origen, cat. no. ORIGSC116333), mouse myoD (CMV-myc-
tagged myoD; Addgene plasmid 8399; principal investigator:
Andrew Lassar), and human ICln (hICln) cDNA or plasmid
DNA were PCR amplified and cloned in frame with the
fluorescent proteins ECFP and EYFP into the pECFP-C1,
pECFP-N1, pEYFP-C1, or pEYFP-N1 (Clontech) mamma-
lian expression vectors. In addition, hICln and hPRMT5
were cloned into the bacterial expression vector pET3-His
[47] for GST-pulldown assays. Murine TIS7 cDNA was
excised from pcDNA3.1-HisC/TIS7 [5] and inserted into
pEGFP-C1 (Clontech). YFP-tagged hICln and GST-mTIS7
were described previously [5, 48]. pGL3B luciferase reporter
constructs incorporating indicated promoter regions of the
human CLNS1A (ICln, GenBank Accession #AP000609)
were described previously [26]. The promoter region of
CLNS1A was originally subcloned into the pBlueskript SKII
+ vector and a 2154 base pair region upstream of the ORF
was subsequently subcloned into the dual luciferase vector
pGL3-Basic (Promega) using KpnI and HindIII. Using this
vector as a template, a 44 base pair region of the ICln
promoter (nucleotides –156 through –113; the positions are
relative to the adenine of the ORF) containing a putative
TIS7 consensus binding sequence was subcloned into
pGL3-Basic, again using KpnI and HindIII and named
pGL3B-hIClnprom156/113. The subcloning PCR primers
were: forward, 5′TACTCGGTACCTAGAATGTCTCATCT
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CTATGG3′ and reverse, 5′AATATAAGCTTCCGGAATC
TGAACGCC3′. To engineer a vector containing two of the
putative TIS7 consensus binding sequences, the same 44
base pair sequence was subcloned into pGL3B-hIClnp
rom156/113 with KpnI and named pGL3B-hIClnprom156/





ACCTATGC3′. Oligonucleotide primers were purchased
from (Microsynth), and the identities of all nucleotides
corresponding to the ICln promoter were verified with se-
quencing (Microsynth) prior to use in experiments. pRDI-
shRNA-PRMT5 plasmid was generated using oligonucleo-
tides with the sequence TAGGATCTCGGTTGGGATG
based on Dharmacon Lentiviral Mouse SMARTvector Cat.
No. V3SM11241-231161284.
Retroviruses and transduction
Retroviruses and transduction were performed as previ-
ously published [49], except for the selective medium
containing 2 μg/mL puromycin (Sigma-Aldrich). Cells
were used for experimental analyses after at least two
rounds of selection.
Antibodies
Affinity purified α-TIS7 and α-ICln rabbit polyclonal
antibodies were described previously [5, 50]. Rabbit
polyclonal antibody against PRMT5 (Millipore, Cat# 07-
405, RRID:AB_310589) was used for western blot in a
1:1000 dilution. Mouse monoclonal α-TIS7 (Cat# T2576,
RRID:AB_477566; 1:2000), α-actinin (Cat# A5044, RRI-
D:AB_476737; 1:2000), and α-tubulin (Cat# T5168, RRI-
D:AB_477579; 1:2,000) antibodies were purchased from
Sigma, α-GFP from Roche (Cat# 11814460001, RRI-
D:AB_390913; 1:1000), mouse monoclonal α-ICln AA 92-
201 (Cat# 611274; 1:1000) and purified mouse anti-MyoD
clone 5.8A ( Cat# 554130; 1:1000) from BD Transduction
Laboratories, α-6× His from Clontech (Cat# 631212;
1:5000), and α-myosin heavy chain (RRID:AB_2147781;
DSHB Hybridoma Product MF 20; 1:1000) from Develop-
mental Studies Hybridoma Bank. Affinity purified goat
polyclonal α-GST was used from Pharmacia (Cat# 27-
4577-01; GE Healthcare). MyoD western blot data were
confirmed by additional experiments using different anti-
bodies. Although both identified a double band (45 and
48 kDa), the specificity of these antibodies was confirmed
by pre-incubation with corresponding peptides, which
blocked both bands. Therefore, both bands were included
for the quantification of MyoD protein levels (Fig. 2c).
The Alexa Fluor488, Alexa Fluor568, and Alexa Fluor 647
conjugated secondary antibodies were purchased from
Molecular Probes (Thermo Fisher Scientific).
Statistics
Results of three experimental repeats or more (indicated as
n = number of observations) are shown as indicated in the
respective figure legend, either as mean ± SD or as mean ±
SEM for variation between experiments. The mean values
for biochemical data from the experimental groups were
compared by performing two-tailed type 2 Student’s t-test. P
values are as follows: *P < 0.05, ** P < 0.01, and *** P < 0.001.
Additional files
Additional file 1: Figure S1. (a) TIS7 KO does not change abundance
of histone H3 on the myoD gene. ChIP analysis using chromatin from
TIS7 WT or KO MSCs. Antisera directed against histone H3 were used for
immunoprecipitation. Immunoprecipitated DNA was analyzed in triplicate
by qPCR using primers specific for myoD regulatory region. ChIP with
control rabbit IgGs or 1.23 % of total chromatin (input) were used as
controls. Signals were normalized to input chromatin and shown as
percentage of input. (b) Expression of PRMT5 in control and PRMT5
knockdown cells. TIS7 KO MSCs were infected with either sh GFP- or sh
PRMT5-expressing lentiviruses. Gene-specific mRNA was quantified using
qRT-PCR and the comparative ddCt method. Values are presented as
mean ± SD. (c, d) ICln does not affect PRMT5 methyltransferase activity.
(c) Myc-tagged PRMT5 was expressed alone or co-expressed with
ICln-YFP in HEK293T cells. Ectopic PRMT5 was immunoprecipitated
from whole cell lysates using anti-myc 9E10 antibody and its
methyltransferase activity was analyzed by in vitro methylation assay
followed by autoradiography (top). Purified core histones were used as
substrates. Coomassie staining shows the relative amount of histones
(middle) and immunoprecipitated PRMT5 (bottom) used in the assay. (d)
Ectopic PRMT5 was purified from HEK293T cells as described in c. The
methylation of histones by PRMT5 containing immunocomplexes was
analyzed in the absence or presence of recombinant purified His-ICln
protein (top). The levels of histones, PRMT5, and ICln proteins were
documented by Coomassie staining of SDS-PAGE (bottom). (JPG 2327 kb)
Additional file 2: Figure S2. Bioinformatics prediction software (DISIS
(www.predictprotein.org), BinDN+ (http://www.mybiosoftware.com/bindn-
bindn-bindn-rf-sequence-based-prediction-of-dna-and-rna-binding.html+/),
DP-Bind (http://lcg.rit.albany.edu/dp-bind/) and DNABindR (http://
www.imtech.res.in/raghava/dnabinder/) identified with 70–80 % probability
DNA-binding domains in TIS7 amino acid sequence. (JPG 3877 kb)
Additional file 3: Raw data relating to each figure. (XLSX 236 kb)
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